The historical rank and industry rank for Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow or its related term are showing as below:
FSPKF'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 31.24 Med: 69.25 Max: 627.17
Current: 544.34
During the past 13 years, Fisher & Paykel Healthcare's highest Price-to-Free-Cash-Flow Ratio was 627.17. The lowest was 31.24. And the median was 69.25.
FSPKF's Price-to-Free-Cash-Flow is ranked worse than 98.19% of 331
companies
in the Medical Devices & Instruments industry
Industry Median: 34.64
vs FSPKF: 544.34
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -43.90% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -17.70% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.40% per year.
During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average Free Cash Flow per Share Growth Rate was 50.60% per year. The lowest was -43.90% per year. And the median was 8.50% per year.
Fisher & Paykel Healthcare Price-to-Free-Cash-Flow Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow falls into.
Fisher & Paykel Healthcare's Share Price of today is $16.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Fisher & Paykel Healthcare Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Business Description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FSPKF has been successfully added to your 